Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 059929/0986 | |
| Pages: | 5 |
| | Recorded: | 05/17/2022 | | |
| Attorney Dkt #: | LIF-202-US-CNT |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17656682
|
Filing Dt:
|
03/28/2022
|
|
Publication #:
|
|
Pub Dt:
|
10/13/2022
| | | | |
|
Title:
|
AGENTS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH UNDESIRED CELL PROLIFERATION
|
|
|
Assignees
|
|
|
|
|
| PASSEIG LLUIS COMPANYS, 23 |
| BARCELONA, SPAIN E-08010 |
|
|
|
|
|
| NATZARET, 115-117 |
| EDIFICI CELLEX |
| BARCELONA, SPAIN 08035 |
|
|
Correspondence name and address
|
| |
ASTRAZENECA PHARMACEUTICALS
|
| |
ONE MEDIMMUNE WAY
|
| |
GAITHERSBURG, MD 20878
|
Search Results as of:
04/28/2024 12:20 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
